Development of an alpha v beta 6 integrin selective oncolytic virotherapy based on the low seroprevalence human adenovirus, HAdV-D10.
HUMAN GENE THERAPY(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined